DR. JUSTIN PARSCHAUER D.O.
Prescription History 1073845921
Ophthalmology in Tulsa, OK
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. JUSTIN PARSCHAUER D.O., an active Ophthalmology specialist practicing in Tulsa, OK. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 96 documented patient claims. Among these therapy options, the most frequently utilized medication is Prednisolone Acetate, which accounts for 39 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other OK PrescribersVs. OK Avg |
|---|---|---|---|
| Prednisolone Acetate | 39 | $36.34▼ below OK avg | ▼ Less than typical |
About Prednisolone Acetate: This medication is used to treat certain eye conditions due to inflammation or injury. Show more ▾ Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids. A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. In 2024, this provider wrote 39 Medicare prescriptions for Prednisolone Acetate, about a third of the volume of the typical Oklahoma prescriber of this medication (97.2). Medicare paid an average of $36.34 per fill, versus $36.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 44.9 30-Day Fills standardized to 30-day supplies 1,057 Days of Medication total across all patients in 2024 | |||
| Ketorolac Tromethamine | 29 | $28.94 | ▼ Less than typical |
About Ketorolac Tromethamine: This medication is used to temporarily relieve itching eyes caused by seasonal allergies. Show more ▾ It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling. A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity. In 2024, this provider wrote 29 Medicare prescriptions for Ketorolac Tromethamine, about a third of the volume of the typical Oklahoma prescriber of this medication (81.9). Medicare paid an average of $28.94 per fill, versus $23.75 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.3 30-Day Fills standardized to 30-day supplies 576 Days of Medication total across all patients in 2024 | |||
| Difluprednate | 15 | $119.25 | ▼ Less than typical |
About Difluprednate: This medication is used to treat swelling and pain after eye surgery. Show more ▾ It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids. In 2024, this provider wrote 15 Medicare prescriptions for Difluprednate, about 62% of the volume of the typical Oklahoma prescriber of this medication (24.1). Medicare paid an average of $119.25 per fill, versus $102.85 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 16.5 30-Day Fills standardized to 30-day supplies 267 Days of Medication total across all patients in 2024 | |||
| CombiganBrimonidine Tartrate/Timolol | 13 | $217.37▼ below OK avg | ▼ Less than typical |
About Combigan: This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Show more ▾ Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details. A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients. In 2024, this provider wrote 13 Medicare prescriptions for Combigan, about half the volume of the typical Oklahoma prescriber of this medication (24.6). Medicare paid an average of $217.37 per fill, versus $340.72 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average OK prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the OK average for this medication. 13 30-Day Fills standardized to 30-day supplies 350 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. JUSTIN PARSCHAUER D.O. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Ophthalmology prescribing approach at this Tulsa, OK practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among OK prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
